were ascertained from the genetic records of the West of Scotland Regional Genetics Centre. All affected subjects conformed to the diagnostic criteria of Gomez' and 
Discussion
The human oncogene c-abl is the cellular homo- logue of the transforming sequence v-abl which was first discovered in the Abelson strain of murine leukaemia virus (A-MuLV). The coding sequences for c-abl extend over a 225 to 300 kb region and the v-abl homologous regions (VAHR) are located at its 3' end.9 Human c-abl has been localised to 9q34 by in situ hybridisation and somatic cell hybrid panels and is transferred to chromosome 22 in the reciprocal translocation which creates the Philadelphia chromosome. 1(014 The adenylate kinase 1 (AK1) linkage group has also been regionally localised to 9q34 by dosage studies using children with various imbalances of chromosome 9,15 but unlike c-abl is not transferred to chromosome 22 in the Philadelphia chromosome'6 which would suggest that c-abl is distal to AK1.
Using c-abl (ablK-2) Barker and White'7 have described diallelic polymorphisms with TaqI, Pstl, AccI, and Stul (each with an infrequent allele frequency of 0.11). The present study using the TaqI polymorphism detected by v-abl has shown linkage to TS and provides further evidence for the assignment of TS to 9q34. This marker will be more useful for early prenatal diagnosis than the ABO or AKI loci and will aid attempts to clone the structural gene for TS.
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